Mytilini Enterprises LLC (Bedford Pharmacy, Inc.), Bedford, NH

Is Mytilini Enterprises LLC (Bedford Pharmacy, Inc.) registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Mytilini Enterprises LLC (Bedford Pharmacy, Inc.) hold a New Hampshire pharmacy license?

State board of pharmacy records for New Hampshire are not checked: this index has not yet added that board’s records.

Has Mytilini Enterprises LLC (Bedford Pharmacy, Inc.) had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (Jan 11, 2021), 1 untitled letter (Oct 4, 2019), 1 state referral letter (Jan 11, 2021) and 1 FMD-145 letter (Jan 11, 2021) for Mytilini Enterprises LLC (Bedford Pharmacy, Inc.). State board of pharmacy records for New Hampshire are not checked: this index has not yet added that board’s records. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Bedford Pharmacy, Inc.; Mytilini Enterprises LLC
Location
Bedford, NH
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
0
Warning letters on FDA’s actions page
0
Latest action on that page
Jan 11, 2021
FDA Data Dashboard inspections
No matching site found
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Bedford Pharmacy, Inc. (dba Mytilini Enterprises LLC), a 503A facility, with 4 dated actions.

Document
Jan 11, 2021State referral letterState Referral Letter Issued 01/11/2021Not linked by FDA
Jan 11, 2021FMD-145 letterFMD-145 Letter Issued 01/11/2021Not linked by FDA
Jan 11, 2021Warning letter close-outWarning Letter Closeout Issued 01/11/2021Not linked by FDA
Oct 4, 2019Untitled letterUntitled Letter Issued 10/4/2019FDA copy (archived)

An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.

The dashboard does list Mytilini Enterprises LLC, Bedford, NH (FEI 3003687986): same name and state, different city, so not treated as this site.

State board of pharmacy records

State board of pharmacy records for New Hampshire are not checked: this index has not yet added that board’s records.

This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.